XML 48 R31.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Quarterly Results of Operations (unaudited) | 12 Months Ended
--- | ---
Dec. 31, 2023
Quarterly Financial Data [Abstract] |
Quarterly Results of Operations (unaudited) | Quarterly Results of Operations (unaudited) The unaudited consolidated quarterly results of operations (in thousands, except per share data) were as follows:
| For the Three Months Ended
| December 31 |  | September 30 |  | June 30 |  | March 31
2023 |  |  |  |  |  |  |
Total revenue | $ | 556,055 |  |  | $ | 511,015 |  |  | $ | 469,136 |  |  | $ | 427,690 |
Total operating expenses | 577,405 |  | 528,953 |  | 490,704 |  | 438,045
Loss before preferred dividends and accretion of Series A Preferred Stock | (33,411) |  | (25,324) |  | (34,323) |  | (19,982)
Dividends and accretion of Series A Preferred Stock | (7,984) |  |  | (7,872) |  |  | (7,088) |  |  | (6,276) |
Net loss attributable to common shareholders of Evolent Health, Inc. | (41,395) |  | (33,196) |  |  | (41,411) |  |  | (26,258) |
Loss per common share |  |  |  |  |  |  |
| For the Three Months Ended
| December 31 |  | September 30 |  | June 30 |  | March 31
Basic and diluted | $ | (0.36) |  |  | $ | (0.30) |  |  | $ | (0.37) |  |  | $ | (0.24) |
2022 |  |  |  |  |  |  |
Total revenue | $ | 382,432 |  |  | $ | 352,585 |  |  | $ | 319,939 |  |  | $ | 297,057 |
Total operating expenses | 384,310 |  | 339,634 |  | 324,572 |  | 299,855
Net income (loss) from continuing operations | (11,349) |  | 2,123 |  | (4,125) |  | (5,350)
Net loss from discontinued operations, net of tax | — |  |  | — |  |  | (463) |  |  | — |
Net income (loss) attributable to common shareholders of Evolent Health, Inc. | (11,349) |  | 2,123 |  | (4,588) |  | (5,350)
Income (loss) per common share |  |  |  |  |  |  |
Basic and diluted | $ | (0.11) |  |  | $ | 0.02 |  |  | $ | (0.05) |  |  | $ | (0.06) |

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialDataAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Publisher FASB -URI https://asc.fasb.org//1943274/2147482964/270-10-50-1B Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 270 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//270/tableOfContent + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration